Vaishali Sanchorawala, MD

Hematologist, Director, Amyloidosis Center, Director, Stem Cell Transplant and Cellular Therapy Program


617.638.6428

My Contact Information

  • Pronouns

    She/Her
Boston Top Docs 2023

Select your language:

More About Me

Vaishali Sanchorawala, MD is a hematologist, Director of the Stem Cell Transplant and Cellular Therapy Program and Director of the Amyloidosis Center at Boston Medical Center (BMC). Dr. Sanchorawala is also the Skinner Professor of Amyloidosis Research in the Department of Medicine at Boston University Chobanian & Avedisian School of Medicine. She is recognized as one of the leading international experts and a key opinion leader in amyloidosis. With numerous publications and meeting presentations, Dr. Sanchorawala is one of the pioneers in the field of clinical research in AL amyloidosis and her work in the treatment of AL amyloidosis has resulted in the evolution of the standard of care. Dr. Sanchorawala is Associate Editor of Amyloid: The Journal of Protein Folding Disorders and former Secretary of the International Society of Amyloidosis.

  • Administrative Title

    Skinner Professor of Amyloidosis Research, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine

  • Residency

    Internal Medicine, Rutgers Health/New Jersey Medical School Residency, 1991-1994

  • Fellowship

    Hematology and Medical Oncology, Boston University Medical Center

  • Board Certifications

    Internal Medicine and Hematology, American Board of Internal Medicine

  • Special Interests

    Amyloidosis, stem cell transplantation, myeloma, clinical trials

  • Languages

    Gujarati, Hindi

Affiliations

Boston University

Boston University is a leading private research institution with two primary campuses in the heart of Boston and programs around the world.

See my Boston University profile

Featured on HealthCity

HealthCity is Boston Medical Center's online publication that explores the most pressing issues in healthcare. At HealthCity, we believe that healthcare must transform itself to become more equitable, sustainable, and open source.